[Federal Register Volume 89, Number 217 (Friday, November 8, 2024)]
[Notices]
[Pages 88774-88776]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25989]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-25-1268; Docket No. CDC-2024-0093]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a continuing information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled Drug Overdose Surveillance and Epidemiology (DOSE). This data 
collection is designed to facilitate rapid identification and tracking 
of Emergency Department (ED) data on eight drug overdose indicators.

DATES: CDC must receive written comments on or before January 7, 2025.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0093 by either of the following methods:
    <bullet> Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
    <bullet> Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: <a href="/cdn-cgi/l/email-protection#4926242b092a2d2a672e263f"><span class="__cf_email__" data-cfemail="335c5e51735057501d545c45">[email protected]</span></a>.

[[Page 88775]]


SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Drug Overdose Surveillance and Epidemiology (DOSE) (OMB Control No. 
0920-1268, Exp. 9/30/2025)--Revision--National Center for Injury 
Prevention and Control (NCIPC), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    In 2022, a total of 107,941 drug overdose deaths occurred, 
corresponding to an age-adjusted rate of 32.6 per 100,000 population, 
quadruple from the 2002 rate (8.2). From 2021 to 2022, the synthetic 
opioid-involved death rate other than methadone increased 4.1%, from 
21.8 to 22.7 per 100,000. The psychostimulant-involved age-adjusted 
death rate increased more than 34 times, from 0.3 in 2002 to 10.4 in 
2022, and two states had a significant increase in non-fatal overdoses 
between 2023 and 2024. In response to the growing severity of the 
opioid overdose epidemic, the US government declared the opioid 
overdose epidemic a public health emergency (PHE) on October 26, 2017. 
The opioid overdose epidemic is one of the U.S. Department of Health 
and Human Services (HHS) top priorities. In 2021, HHS expanded their 
Overdose Prevention Strategy to focus on four strategic priorities: 
primary prevention, harm reduction, evidence-based treatment, and 
recovery support.
    Drug Overdose Surveillance and Epidemiology (DOSE) 2.0 is made 
possible because the vast majority of the participating health 
departments are already rapidly collecting extensive data on Emergency 
Department (ED) visits in their jurisdiction and using these data for 
the identification of public health concerns including flu and other 
respiratory illnesses, heat-related illness, and hurricane-related 
health issues. DOSE 1.0 ensured participating jurisdictions use their 
data to track suspected overdoses by providing participating 
jurisdictions standardized definitions of ED visits involving all drug, 
all opioid, heroin and all stimulant overdoses. To further advance 
overdose surveillance, for DOSE 2.0, CDC added four additional drug 
indicators--fentanyl, cocaine, methamphetamine, and benzodiazepine. 
This facilitates rapid identification and tracking of ED data on a 
total of eight drug overdose indicators.
    Also, no single ED surveillance system has national coverage, but 
almost all participating health departments use one of three systems--
the NSSP BioSense System, local ED syndromic surveillance, or ED/
inpatient hospital discharge overdose data files. DOSE 2.0 integrates 
data across these three types of ED surveillance to quickly build a 
national surveillance system while leveraging existing ED data 
collection efforts. DOSE 2.0 can use data across the three types of ED 
surveillance systems because the key data requirement is the ability to 
detect change over time (e.g., data consistently collected within the 
jurisdiction overtime) and not comparability across participating 
health departments (e.g., same data collection methods deployed across 
state health departments overtime).
    CDC is requesting OMB approval for three years with an annual 
estimated burden of 655 hours. There is no cost to respondents other 
than their time to participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                            Average      Total
                                                                 Number of    Responses    burden per    annual
          Type of respondent                  Form name         respondents      per        response     burden
                                                                              respondent    (hours)     (hours)
----------------------------------------------------------------------------------------------------------------
Participating health departments       Rapid ED overdose data            45           12          0.5        270
 sharing aggregate data from NSSP       form.
 BioSense.
Participating health departments       Rapid ED overdose data             3           12            3        108
 sharing aggregate data from local      form.
 syndromic data file.
Participating health department        ED and hospitalization            32            1            3         96
 sharing finalized ED and inpatient     discharge overdose
 hospitalization aggregate data on      data form.
 total ED/inpatient hospitalization
 visits, and metadata on a yearly
 basis.
Participating health department        Inpatient                          3            1            2          6
 sharing finalized aggregate data on    hospitalization
 total inpatient hospitalization        discharge overdose
 visits, and metadata on a yearly       data form.
 basis.
Participating health department        .......................           35            1            5        175
 sharing line-level ED/inpatient
 hospitalization discharge data
 (.csv) on drug overdose-related
 visits (i.e., any visit with an ICD-
 10-CM code between T36-T50,
 including all intents, encounters,
 underdosing, and adverse effects.
                                                               -------------------------------------------------

[[Page 88776]]

 
    Total............................  .......................  ...........  ...........  ...........        655
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-25989 Filed 11-7-24; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>